| Quarter | Prior | Estimate | Actual | Surprise | |
|---|---|---|---|---|---|
| Q2 2020 After-Hours | EPS: REV: | ||||
| Q1 2020 After-Hours | EPS: REV: | -0.14 0 | |||
| Q4 2019 After-Hours | EPS: REV: | -0.17 | |||
| Q3 2019 After-Hours | EPS: REV: | -0.16 | |||
| Q2 2019 After-Hours | EPS: REV: | -0.16 0 | -0.15 | -0.13 0 | 13.33% |
| Q1 2019 After-Hours | EPS: REV: | -0.23 0 | -0.15 | -0.14 0 | 6.67% |
| Q4 2018 After-Hours | EPS: REV: | -0.12 | -0.14 | -0.17 | 21.43% |
| Q3 2018 After-Hours | EPS: REV: | -0.11 | -0.15 | -0.16 | 6.67% |
| Q2 2018 After-Hours | EPS: REV: | -0.12 | -0.15 | -0.16 | 6.67% |
| Q1 2018 After-Hours | EPS: REV: | -0.19 | -0.14 | -0.23 | 64.29% |
Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!
News Coverage
- 10 Stocks To Watch For October 17, 2019
- Earnings Scheduled For October 17, 2019
- CSX Improves Operating Ratio In The Third Quarter
- 5 Stocks Moving In Wednesday's After-Hours Session
- Cannabis Stock Gainers And Losers From October 16, 2019
- IBM Shares Fall After Q3 Sales Miss
- Netflix Trades Higher After Q3 Earnings Beat, Subscriber Growth
- Mid-Afternoon Market Update: Crude Oil Up 1%; Tech Data Shares Spike Higher
- Analysts, Investors Like Johnson & Johnson's Improvement, But Lawsuits Loom
- Mid-Day Market Update: Achillion Pharmaceuticals Jumps Following Acquisition News; Natera Shares Plunge
